ethrower on DSK3G9T082PROD with NOTICES

Federal Register / Vol. 82, No. 246 / Tuesday, December 26, 2017 / Notices 61015 

The burden for this information 

collection has changed since the last 

OMB approval. Because of a slight 

increase in the number of initial 

registrations and product listing updates 

FDA has received during the past 3 

years, we have increased our reporting 

burden estimate. 

Lesli

Dated: December 20, 2017. 

e Kux, 

[F

Associate Commissioner for Policy. 

R Doc. 2017–27757 Filed 12–22–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Decision To Evaluate a Petition To 

Designate a Class of Employees From 

the Ames Laboratory in Ames, Iowa, 

To Be Included in the Special 

Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: NIOSH gives notice of a 

decision to evaluate a petition to 

designate a class of employees from the 

Ames Laboratory in Ames, Iowa, to be 

included in the Special Exposure Cohort 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 1090 Tusculum 

Avenue, MS C–46, Cincinnati, OH 

45226–1938, Telephone 877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: 

Authority: 42 CFR 83.9–83.12. 

Pursuant to 42 CFR 83.12, the initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Ames Laboratory. 

Location: Ames, Iowa. 

Job Titles and/or Job Duties: ‘‘All 

employees of the Department of Energy, 

its predecessor agencies, and their 

contractors and subcontractors who 

worked in any area at the Ames 

Laboratory in Ames, Iowa, during the 

period from January 1, 1971 through 

December 31, 1989, for a number of 

work days aggregating at least 250 work 

days, occurring either solely under this 

employment or in combination with 

work days within the parameters 

established for one or more other classes 

of employees included in the Special 

Exposure Cohort.’’ 

Period of Employment: January 1, 

1971 through December 31, 1989. 

Frank Hearl 

Chief of Staff, National Institute for 

Occupational Safety and Health. 

[FR Doc. 2017–27724 Filed 12–22–17; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; 

Developmental Programming and Aging. 

Date: January 17, 2018. 

Time: 11:00 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, Suite 2W200, 7201 

Wisconsin Ave., Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Greg Bissonette, Ph.D., 

Scientific Review Officer, National Institute 

on Aging, National Institutes of Health, 

Gateway Building, Suite 2W200, 7201 

Wisconsin Avenue, Bethesda, MD 20892, 

301–402–1622, bissonettegb@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 18, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–27643 Filed 12–22–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director; Notice of Charter 

Renewal 

In accordance with Title 41 of the 

U.S. Code of Federal Regulations, 

Section 102–3.65(a), notice is hereby 

given that the Charter for PubMed 

Central National Advisory Committee 

(PubMed) was renewed for an 

additional two-year period on December 

8, 2017. 

It is determined that the PubMed is in 

the public interest in connection with 

the performance of duties imposed on 

the National Institutes of Health by law, 

and that these duties can best be 

performed through the advice and 

counsel of this group. 

Inquiries may be directed to Claire 

Harris, Acting Director, Office of Federal 

Advisory Committee Policy, Office of 

the Director, National Institutes of 

Health, 6701 Democracy Boulevard, 

Suite 1000, Bethesda, Maryland 20892 

(Mail Code 4875), Telephone (301) 496– 

2123, or harriscl@mail.nih.gov. 

Dated: December 20, 2017. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–27792 Filed 12–22–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee. 

Date: January 12, 2018. 

Time: 11:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications.